1. Rat liver tryptophan pyrrolase haem is maximally depleted at 30 min after administration of a 400mg/kg dose of 2-allyl-2-isopropylacetamide. This depletion lasts for 24h, by which time 5-aminolaevulinate synthase activity becomes maximally enhanced. 2. though the above maximum depletion of pyrrolase haem (at 0.5 h) is also produced by a 100mg/kg dose of the porphyrogen, this does not enhance synthase activity at 24h.
(Received 13 August 1979) 1. Rat liver tryptophan pyrrolase haem is maximally depleted at 30 min after administration of a 400mg/kg dose of 2-allyl-2-isopropylacetamide. This depletion lasts for 24h, by which time 5-aminolaevulinate synthase activity becomes maximally enhanced. 2. though the above maximum depletion of pyrrolase haem (at 0.5 h) is also produced by a 100mg/kg dose of the porphyrogen, this does not enhance synthase activity at 24h.
It and smaller doses, however, cause a smaller but earlier enhancement of synthase activity (maximum at 2h) and produce a similarly short-lived depletion of pyrrolase haem. 3. The depletion of pyrrolase haem and the enhancement of synthase activity by the porphyrogen are inhibited by compound SKF 525-A and phenazine methosulphate, and are potentiated by nicotinamide but not by phenobarbitone. Phenazine methosulphate and nicotinamide also exert opposite effects on hexobarbital sleeping-time. 4. 2-Allyl-2-isopropylacetamide also depletes pyrrolase haem in vitro. It does so in liver homogenates of control rats in the presence, and in those of phenobarbitone-treated rats in the absence, of added NADPH. 5 . A discussion of the present results in relation to previous work with other haemoproteins suggests that, whereas cytochrome P-450 (haem) is primarily involved in the production of the active (porphyrogenic) metabolite(s) of 2-allyl-2-isopropylacetamide, the haem pool used by tryptophan pyrrolase may play an important role in the effects of this compound on haem biosynthesis. 5-Aminolaevulinate synthase (EC 2.3.1.37), the rate-limiting enzyme of the haem-biosynthetic pathway, is the point at which haem is thought to regulate its own synthesis by a negative feedback mechanism(s) in avian (Granick, 1966; Granick et al., 1975) and mammalian (De Matteis, 1972a) [including possibly also human (Jeelani Dhar et al., 1975) ] liver. This concept has arisen from work on the effects of several chemicals on synthase activity. Whereas avian liver does not discriminate between these chemicals, probably because of the greater sensitivity of its synthase and the lability of its haembiosynthetic pathway (Granick, 1966; Creighton & Marks, 1972; De Matteis, 1973) , mammalian liver responds to chemicals in two ways. Thus a number of chemically unrelated compounds (porphyrogens) stimulate the hepatic formation of porphyrins and markedly enhance the synthase activity (De Matteis, 1967) , whereas several lipid-soluble drugs (including phenobarbitone) cause a moderate enhancement of synthase activity and an increase in Vol. 186 the concentration of microsomal haem, but not in that of porphyrins (see De Matteis, 1972b) . When, however, one of these lipid-soluble drugs is administered together with a porphyrogen to intact animals (De Matteis & Gibbs, 1972) or to isolated perfused livers (Bock et al., 1973) , it potentiates the effects of the porphyrogen on synthase activity and porphyrin concentration, and the above two groups of workers suggested that this potentiation may explain the exacerbation by drugs of human hepatic porphyrias.
The mechanism(s) by which lipid-soluble drugs cause a moderate enhancement of mammalian liver synthase activity is not understood (see Badawy, 1978) . By contrast, it is most likely that the marked enhancement of synthase activity caused by porphyrogens is produced by interference with the above negative-feedback mechanism involving the occurrence of an early depletion of liver haem. It is therefore reasonable to suggest that this haem belongs to the so-called regulatory free-haem pool that has been suggested (Granick et al., 1975; De Matteis, 1975) to be small and rapidly turning over. Since such a pool would be too small to be measured directly, the above depletion of haem has been demonstrated by indirect methods involving the determination of activity or concentration of, or haem utilization by, the hepatic haemoproteins catalase (EC 1.11.1.6), cytochrome P-450 and tryptophan pyrrolase (tryptophan 2,3-dioxygenase, EC 1.13.11.11). There is considerable evidence (see Badawy, 1978 , and references cited therein) implicating this early depletion of mammalian liver haem in the production of experimental porphyria and its exacerbation by drugs.
Our work demonstrating the versatile role of tryptophan pyrrolase and its advantages over other hepatic haemoproteins in relation to haem utilization (for a review, see Badawy, 1979) suggests that, in addition to being a very sensitive marker for assessing delicate changes in liver haem concentration, pyrrolase may play an important role in the regulation of haem biosynthesis. As a first step in studying this latter possibility, we have examined in the present paper the relationship between the early depletion of rat liver tryptophan pyrrolase haem and the marked enhancement of 5-aminolaevulinate synthase activity caused by administration of the porphyrogen 2-allyl-2-isopropylacetamide.
Materials and Methods Chemicals
The sources of most chemicals have been described (Badawy & Evans, 1975a , 1976 Chemical, enzymic and other determinations Tryptophan pyrrolase activity was determined in liver homogenates (Badawy & Evans, 1975a) in either the absence (holoenzyme activity) or the presence (total enzyme activity) of added (2pM) haematin. The apoenzyme activity, obtained by difference, was used to calculate the haem-saturation ratio (that of holoenzyme/apoenzyme activity) which indicates the extent of the haem saturation of the apoenzyme (see also Badawy, 1978 also Badawy, , 1979 . When tested in vitro, 2-allyl-2-isopropylacetamide and NADPH were added in concentrations of 28.4#M and 2 mm respectively.
Hexobarbital sleeping-time was taken as the time elapsing between the onset of anaesthesia after intraperitoneal administration of a 100mg/kg dose of the drug and the regaining of the righting reflex (Bond & De Matteis, 1969) .
5-Aminolaevulinate synthase activity was determined by measuring the enzymically produced (Yoda et al., 1974) 
Results
Assessment of changes in the haem-saturation ratio oftryptophan pyrrolase
An important requirement for this assessment (for a discussion, see Badawy, 1978) is that an administered agent (e.g. 2-allyl-2-isopropylacetamide in the present work) must not be allowed to modify pyrrolase activities by a mechanism(s) other than an altered haem availability. This requirement is met by the use of starved rats, in which the hormonally induced increases in both holoenzyme and total enzyme activities (see Badawy, 1977) forestall any stress-induced enhancement. Although the above porphyrogen caused such an enhancement in 24 hstarved rats (Badawy, 1978) , it did not do so in the 48 h-starved animals used in the present work.
Effects of administration of 2-allyl-2-isopropylacetamide on rat liver tryptophan pyrrolase activity and the haem-saturation ratio
The time-course of these effects of a 400mg/kg dose is shown in Fig. 1 . The total pyrrolase activity was not significantly altered (P > 0.10) at any of the time-intervals examined. By contrast, the holoenzyme activity was decreased by 59% (P <0.005) as early as 15 min after the injection. The decrease reached a maximum (76%; P<0.001) at 30min and was followed by a gradual but partial recovery of the holoenzyme to two-thirds of the basal value at 4 h. No further increase occurred until after 16 h, when the basal value was reached at 24-30h. This was then followed by a 28% increase (P<0.05) at 36h and a final return to normal at 54 h. The haemsaturation ratio was also decreased by 2-allyl-2-isopropylacetamide from a control value (at zero time) of 1.00 to values of between 0.16 and 0.74 at 0.25-24h. It then increased to up to 2.36 (at 36h) and finally fell to the basal value at 48 h.
The effects of various doses of 2-allyl-2-isopropylacetamide were also examined at 0.5h (Fig.  2) . None of the doses tested exerted any significant effect on the total pyrrolase activity (P>0.10). By contrast, the 12.5mg/kg dose caused a small (17%) but significant (P<0.025) decrease in that of the holoenzyme. The decrease was dose-dependent, with the 100mg/kg dose causing the maximum effect (about 60%; P <0.001). The haem-saturation ratio was also decreased (from a control value of 1.00) by 24-75%; the decreases were significant (P = 0.05-0.001), except that of the 12.5 mg/kg dose (P>0.10).
The time-course of the effects of a 100mg/kg dose of 2-allyl-2-isopropylacetamide on pyrrolase activity and the ratio is shown in Fig. 3 . Whereas no significant changes in the total enzyme activity occurred (P> 0.10), that of the holoenzyme was decreased by 47% (P<0.001) at 0.5h. The decrease was 23% (P <0.005) at 2 h. The holoenzyme activity remained unaltered for a further 1 h before returning to the basal value at 5 h.
The effects of pretreatment of rats with compound SKF 525-A, phenazine methosulphate, nicotinamide and phenobarbitone on the haem-depleting action of 2-allyl-2-isopropylacetamide (100mg/kg; 0.5 h before death) are shown in Table 1 . The above dose of the porphyrogen decreased the holoenzyme activity and the ratio by 32-47 and 50-60% respectively (P =0.05-0.001). None of the above four compounds exerted any significant effects on pyrrolase activities or ratio in control rats. Both compound SKF 525-A and phenazine methosulphate prevented the porphyrogen-induced decreases in holoenzyme activity and the ratio. By contrast, nicotinamide enhanced the porphyrogen effects on these two parameters by 23 and 28% respectively (P = 0.05-0.02). Phenobarbitone injections, on the other hand, did not modify the effects of 2-allyl-2-isopropylacetamide (P > 0.10). Similar Table 1 . Effects of pretreatment of rats with various agents on the 2-allyl-2-isopropylacetamide-induced depletion of liver tryptophan pyrrolase haem Rats were starved for 48h before being killed and were given (at 0.5 h before death) a subcutaneous injection of either 2-allyl-2-isopropylacetamide (100mg/kg) or an equal volume (1 ml/kg) of the solvent dimethylformamide. Pretreatments consisted of giving compound SKF 525-A (45mg/kg) 45min, phenazine methosulphate (10mg/kg) 10min, nicotinamide (100mg/litre of drinking water) 72h, or phenobarbitone sodium (50, 50 and 80mg/kg) respectively 48, 42 and 24h, before the above treatments. Control rats received the appropriate pretreatments with 0.9% NaCl or drinking water (Nil) for the same durations. The enzyme activity was determined as described in the Materials and Methods section in either the absence (holoenzyme activity) or the presence (total enzyme activity) of added haematin. The apoenzyme activity, obtained by difference, was used to calculate the haemsaturation ratio (that of holoenzyme/apoenzyme activity). Values are means ± S.E.M. for each group of four rats. The effects of 2-allyl-2-isopropylacetmide (in columns 4 and 6) are compared with those of dimethylformamide (columns 1 and 3), whereas only one difference was found in dimethylformamide-treated rats (in the total activity after nicotinamide administration). Significance of differences is indicated as follows: *P <0.05; **P<0.02; ***P < 0.0 1; tP < 0.005; ttP < 0.00 1.
Haem but was shorEffects in vitro of 2-allyl-2-isopropylacetamide, NADPH or both on rat liver tryptophan pyrrolase activity and the haem-saturation ratio The above effects in 48 h-starved rats were examined in untreated rats and in those given multiple injections of phenobarbitone (Table 2) . In untreated rats, neither the porphyrogen alone nor NADPH alone exerted any significant effects (P> 0.01) on pyrrolase activities or the ratio. Addition of the two together, however, decreased the holoenzyme activity and the ratio by 42 and 54% respectively (P =0.02-0.001). In phenobarbitonetreated rats, NADPH alone exerted no significant effects, whereas 2-allyl-2-isopropylacetamide alone decreased the holoenzyme activity by 21% (P < 0.05), but the decrease in the ratio was not significant. Addition of both agents together caused further decreases in holoenzyme activity and the ratio; the combined decreases (compared with control values) were 43 and 57% respectively (P= 0.05-0.005).
The control pyrrolase activities in Table 2 are lower than those observed after administration of phenobarbitone. This difference did not affect the haem-saturation ratio and may be explained by the absence of treatment of control rats with multiple injections of 0.9% NaCl, because, when this was performed, both control and phenobarbitone-treated rats had similar enzyme activities (Table 1 ). This also suggests that phenobarbitone injection(s) does not influence tryptophan pyrrolase activities, a finding that has previously been reported (Badawy & Evans, 1973b) . Effects of administration of 2-allyl-2-isopropylacetamide on rat liver 5-aminolaevulinate synthase activity
The time-course of the effects of a 400mg/kg dose is shown in Fig. 4 . At 1 h, synthase activity was increased by 95% (P <0.05). The Fig. 5 . A 69% increase (P<0.001) Table 2 . Effects in vitro of 2-allyl-2-isopropylacetamide, NADPH or both on rat liver tryptophan pyrrolase activity and the haem-saturation ratio Rats were starved for 48 h before being killed. Some rats received injections of phenobarbitone sodium (50, 50 and 80mg/kg) respectively at 48, 42 and 24h before death. Liver homogenates were incubated in the absence or the presence of 2-allyl-2-isopropylacetamide (28.4 pM), NADPH (2mM) or both. The enzyme activity was determined as described in the Materials and Methods section in either the absence (holoenzyme activity) or the presence (total enzyme activity) of added haematin. The apoenzyme activity, obtained by difference, was used to calculate the haem-saturation ratio (that of holoenzyme/apoenzyme activity). Values are means+ S.E.M. for each group of four rats. All differences are in relation to the results in column (1) 8 20Time (h)32 Fig. 4 . Time-course of the effects of administration of 2-allyl-2-isopropylacetamide (400mg/kg) on rat liver 5-aminolaevulinate synthase activity Rats were starved for 48 h before being killed and were given 2-allyl-2-isopropylacetamide (400mg/kg) subcutaneously at zero time. The enzyme activity was determined as described in the Materials and Methods section. Values are means + S.E.M. for each group of four rats.
occurred at 1 h and was followed by maximum enhancement (390%; P < 0.001) 1 h later. Activity then fell, reaching 2.23-fold the basal value at 5 h.
The effects of various doses of 2-allyl-2-isopropylacetamide were also examined at 2 and 24 h (Fig. 6) . At 2 h, the 12.5mg/kg dose caused a 156% increase (P < 0.001), whereas the 25 mg/kg dose caused maximum enhancement (422%; P <0.001).
By contrast, doses of the porphyrogen of 100mg/kg and below failed to alter synthase activity at 24 h. Enhancement at-this time-interval was maximum (850%; P < 0.001) with the 300 mg/kg dose. The effects of pretreatment of rats with compound SKF 525-A, phenazine methosulphate, nicotinamide and phenobarbitone on the enhancement of synthase activity observed at 2h after administration of a 100mg/kg dose of 2-allyl-2-isopropylacetamide are shown in Table 3 . None of the above four compounds exerted any significant effects (P>0.10) on synthase activity of control rats. Synthase enhancement by 2-allyl-2-isopropylacetamide was de- creased by compound SKF 525-A and phenazine methosulphate. Direct comparison of results suggests that the decreases by these two agents were 32 and 51% respectively (P = 0.02-0.05), but a comparison of the net effects of 2-allyl-2-isopropylacetamide shows that the decreases were 65 and 87% respectively. By contrast, nicotinamide enhanced the effect of the porphyrogen on synthase activity by allyl-2-isopropylacetamide on rat liver 5-aminolaevulinate synthase activity Rats were starved for 48 h before being killed and were given various doses of 2-allyl-2-isopropylacetamide or an equal volume (1 ml/kg) of the solvent dimethylformamide at 2 (0) or 24h (-) before death. The enzyme activity was determined as described in the Materials and Methods section. Values are means + S.E.M. for each group of four rats. Table 3 . Effects of pretreatment of rats with various agents on the 2-allyl-2-isopropylacetamide-induced enhancement ofliver 5-aminolaevulinate synthase activity Experimental details are as described in Table 1 , except that the animals were killed at 2h after administration of 2-allyl-2-isopropylacetamide or the solvent dimethylformamide. Synthase activity was determined as described in the Materials and Methods section. Values are means ± S.E.M. for each group of four rats. The results in column (2) are compared with those in column (1) and significance of differences is indicated as follows: *P<0.025; ***P < 0.01; ttP < 0.001. 25% (P <0.02) (direct comparison) or by 44% (of net effect). Phenobarbitone injections, on the other hand, caused a small (22%) decrease (P>0.10) in the porphyrogen-induced enhancement of synthase activity. A single phenobarbitone dose (5mg/kg) given 15min before the porphyrogen (100mg/kg) did not influence synthase enhancement either. The enzyme activities (in nmol of 5-aminolaevulinate formed/min per g wet wt. of liver, ±S.E.M. for ech group of four rats) were as follows: control (1.36 + 0.17); phenobarbitone (1.37 + 0.16); 2-allyl-2-isopropylacetamide (2.83 + 0.33); 2-allyl-2-isopropylacetamide plus phenobarbitone (2.87 + 0.55).
Discussion
Depletion of tryptophan pyrrolase haem by 2-allyl-2-isopropylacetamide Preferential depletion of rat liver tryptophan pyrrolase haem is a very early phenomenon in the sequence of events leading to the production of porphyria by 2-allyl-2-isopropylacetamide. Thus, whereas decreases in concentrations of cytochrome P-450 and catalase of only 9-27% (under basal conditions) occur at 1-2 h (Satyanarayana Rao et al., 1972) , the depletion of pyrrolase haem is maximum (76%) at 30min (Fig. 1) . Moreover, the finding (Fig. 1) that the partial recovery of pyrrolase haem (at 5 h) is interrupted for 11 h, whereas the recovery of cytochrome P-450 is not (see also De Matteis, 1971), suggests that pyrrolase haem remains a constant target for most of the time-course of enhancement of 5-aminolaevulinate synthase activity by the above porphyrogen (see Fig. 4 ). These changes, together with the sensitivity of pyrrolase haem to very small doses of 2-allyl-2-isopropylacetamide (Fig. 2) , strongly suggest that depletion of pyrrolase haem may play an important role in the action(s) of this porphyrogen on liver haem metabolism, in view of the importance of haem depletion in synthase enhancement (see the introduction).
2-Allyl-2-isopropylacetamide depletes liver haem by causing its destruction to green and other unidentified pigments by an ill-defined process mediated by a metabolite(s) of the porphyrogen produced by the microsomal NADPH-dependent mixed-function oxidase system. This conclusion is based on the findings (see De Matteis, 1971 ) that compound SKF 525-A, an inhibitor of the above oxidase system (Fouts & Brodie, 1955) , prevents both the loss of cytochrome P-450 and the production of green pigments, whereas the mixed-functionoxidase inducer phenobarbitone potentiates both effects. It should be pointed out here that phenobarbitone achieves its effects only at the expense of newly synthesized cytochrome P-450 (see also Unseld & De Matteis, 1978) . We have previously shown (Badawy & Evans, 1973b) that the 2-allyl-2-isopropylacetamide-induced depletion of pyrrolase haem in fed rats is prevented by compound SKF 525-A. The results in Table 1 show that this latter compound is also effective in 48h-starved rats. By contrast, pretreatment with phenobarbitone in the doses used by De Matteis (1971) to induce cytochrome P-450 synthesis does not modify the action of 2-allyl-2-isopropylacetamide on pyrrolase haem. The following conclusions may be drawn from this finding: (1) the failure of phenobarbitone is not surprising, because it does not alter haem concentration of the basal pyrrolase; (2) the fact that this is so suggests that tryptophan pyrrolase assayed in whole homogenates does not utilize the increase in microsomal haem concentration produced by this phenobarbitone treatment.
The 2-allyl-2-isopropylacetamide-induced depletion of tryptophan pyrrolase haem can be modified in opposite directions by pretreatment of rats with phenazine methosulphate and nicotinamide ( Badawy & Evans, 1976) or by another mechanism(s). Further work is required to examine these possibilities.
2-Allyl-2-isopropylacetamide depletes cytochrome P-450 (De Matteis, 1971) and destroys both endogenous microsomal haem and that administered exogenously (Unseld & De Matteis, 1978) in vitro only in the presence of an added NADPHgenerating system. The results in Table 2 Badawy & Evans, 1973a , 1975b , and by suggesting that pyrrolase haem is preferentially affected in vitro in the presence of a small but sufficient amount of the metabolite(s) of 2-allyl-2-isopropylacetamide.
Relationship between depletion of tryptophan pyrrolase haem and enhancement of 5-aminolaevulinate synthase activity by 2-allyl-2-isopropylacetamide
The marked enhancement of 5-aminolaevulinate synthase activity by the above porphyrogen (Fig. 4) exhibits two important features: (1) it is preceded by the depletion of pyrrolase haem (Fig. 1) ; (2) it is interrupted at 4h after porphyrogen administration. This interruption is not apparent from the lessdetailed time-course reported by Marver et al. (1966a,b) . It may be of interest that the onset of this interruption (at 4h) coincides with the interruption of the recovery of pyrrolase haem (Fig 1) , although the latter interruption persists for 12h more. These findings and that showing that the depletion of cytochrome P-450 continues unhindered for the whole 8h observation period (Unseld & De Matteis, 1978) suggest that the depletion of pyrrolase haem is more closely associated with synthase enhancement by the above porphyrogen. Although the maximum depletion of pyrrolase haem (at 0.5h) is achieved by a 100mg/kg dose of 2-allyl-2-isopropylacetamide (Fig. 2) (Fig. 6) ; (4) it is also known (White & Muller-Eberhard, 1977 ) that agents such as norethindrone and ethynyloestradiol cause a maximum enhancement of synthase activity (by a mechanism resembling that by 2-allyl-2-isopropylacetamide) at 2 h, and their depletion of (cytochrome P-450) haem is also shortlived. It should be pointed out here that the depletion of cytochrome P-450 shown by the above authors is only significant at 2h, but not earlier. It therefore remains to be seen whether these steroids exert an earlier effect on tryptophan pyrrolase haem. The findings discussed so far suggest that the enhancement of 5-aminolaevulinate synthase activity by 2-allyl-2-isopropylacetamide need only be explained by the depletion of tryptophan pyrrolase haem. This is also because, although the effects of small doses of 2-allyl-2-isopropylacetamide on cytochrome P-450 haem have not been examined under basal conditions, it is unlikely that these doses will cause a significant change, because only a moderate depletion of cytochrome P-450 is observed early after administration of doses of 300-400mg/kg (De Matteis, 1971; Satyanarayana Rao et al., 1972) . The importance of the very small haem pool used by tryptophan pyrrolase in the effects of the above porphyrogen on synthase activity is further suggested by the now accepted view that the regulatory freehaem pool [which is utilized by tryptophan pyrrolase (Badawy, 1979) ] is small and rapidly turning over (De Matteis, 1975; Granick et al., 1975) . By adopting this concept, a number of findings can now be more readily explained. (1) The failure of multiple injections of phenobarbitone to potentiate the effect of 2-allyl-2-isopropylacetamide on 5-aminolaevulinate synthase activity at 5 (De Matteis, 1971) or 2 h (Table 3) , despite the greater depletion of cytochrome P-450 haem (De Matteis, 1971) , and the finding ( Table 1) that tryptophan pyrrolase haem is not further depleted under these conditions provide further support to the possible involvement of this (pyrrolase) haem pool in the action of the above porphyrogen on synthase activity, because when the porphyrogen-induced depletion of pyrrolase haem is influenced by compound SKF 525-A, phenazine methosulphate and nicotinamide (Table 1) , parallel changes in synthase activity are observed (Table 3) . The inability of phenazine methosulphate completely to inhibit synthase enhancement at 2h after porphyrogen administration may be explained by the short-lived effect of the former compound on liver [NADPH] . (2) Non-involvement of cytochrome P-450 haem in the potentiation of the enhancement of 5-aminolaevulinate synthase activity by the porphyrogen 3,5-diethoxycarbonyl-1 ,4-dihydrocollidine is suggested by the failure of the potentiator phenylbutazone to cause a further early depletion of the above haem (De Matteis & Gibbs, 1972) , whereas under these and several other conditions involving potentiation of experimetnal porphyria, tryptophan pyrrolase haem is further depleted (Badawy, 1978) . (3) The findings of the present paper and those discussed above provide an alternative to the suggested (Fig.   6 ).
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In conclusion, the present results are compatible with the hypothesis that tryptophan pyrrolase haem plays an important role in the enhancement of 5-aminolaevulinate synthase activity by 2-allyl-2-isopropylacetamide, and that cytochrome P-450 haem is primarily involved in the production from the above porphyrogen of the active metabolite(s) responsible for the changes in haem destruction and biosynthesis.
